# Filing Detail

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001144204-19-019677
Filing Date
2019-04-15
Accepted
2019-04-15 16:05:39
Documents
3
Effectiveness Date
2019-04-15

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | DEFA14A | tv518884_defa14a.htm | DEFA14A | 21654
2 | GRAPHIC | image_001.jpg | GRAPHIC | 460049
3 | GRAPHIC | image_002.jpg | GRAPHIC | 560305
| Complete submission text file | 0001144204-19-019677.txt |  | 1428322

Mailing Address 3579 VALLEY CENTRE DRIVE SAN DIEGO CA 92130
Business Address 3579 VALLEY CENTRE DRIVE SAN DIEGO CA 92130 804-827-2524
AmpliPhi Biosciences Corp (Filer) CIK: 0000921114 (see all company filings)

EIN.: 911549568 | State of Incorp.: WA | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-37544 | Film No.: 19748648
SIC: 2836 Biological Products, (No Diagnostic Substances)